Categories AlphaGraphs, Consumer, Earnings

Earnings Infographic: Highlights of Nike’s Q3 2023 results

Sportswear giant Nike, Inc. (NYSE: NKE) on Tuesday reported a decrease in earnings for the third quarter of 2023, when its revenues increased by 14%.

Nike Q3 2023 earnings infographic

Third-quarter net income was $1.24 billion or $0.79 per share, compared to $1.40 billion or $0.87 per share in the corresponding period of fiscal 2022. The bottom line was negatively impacted by an increase in operating expenses.

February-quarter revenues grew 14% from last year to $12.40 billion. NIKE Direct sales were $5.3 billion, up 17% from the prior-year quarter 


Check this space to read management/analysts’ comments on Nike’s Q3 2023 earnings


“NIKE’s brand distinction and strong execution continue to create separation in the marketplace. We have made tremendous progress on inventory as we position NIKE for sustainable and more profitable growth,” said Matthew Friend, Nike’s chief financial officer.

Prior Performance

  • Nike Q2 2023 earnings infographic
  • Nike Q1 2023 earnings infographic
  • Nike Q4 2022 earnings infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Take-Two Interactive Software (TTWO) Earnings: 4Q24 Key Numbers

Take-Two Interactive Software, Inc. (NASDAQ: TTWO) reported net revenue of $1.40 billion for the fourth quarter of 2024, which was down 3% year-over-year. Net loss was $2.90 billion, or $17.02

Applied Materials (AMAT) Earnings: 2Q24 Key Numbers

Applied Materials, Inc. (NASDAQ: AMAT) reported revenue of $6.65 billion for the second quarter of 2024, which remained flat year-over-year. GAAP net income increased 9% to $1.72 billion and EPS

What to expect when Macy’s (M) reports its Q1 2024 earnings results

Shares of Macy’s, Inc. (NYSE: M) stayed green on Thursday. The stock has gained 23% over the past 12 months. The retailer is scheduled to report its first quarter 2024

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top